AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer

First prospective study of its kind conducted in primary care settings, shows remarkable diagnostic performance: 95%…